-
Rozpoczęcie budowy piątego zakładu produkcyjnego
TIMELINES oninFerring rozpoczął budowę swojego piątego zakładu produkcyjnego w Saint-Prex w Szwajcarii, co podkreśla zaangażowanie firmy w rozwój tego regionu.
00 -
Ferring Pharmaceuticals to build state of the art production site in Saint-Prex
inFerring Pharmaceuticals, world pioneer and leader in industrial synthetic peptides, breaks ground for a new manufacturing site in Saint-Prex, canton of Vaud. The company will invest…
-
The Incredible Egg
inWorld renowned infertility clinicians and scientists gather to debate the newest research into the complexities of human eggs (oocytes) which form the basis of the human embryo…
-
Counting the Costs of Nightly Visits to the Bathroom – Businesses lose € 14 million Euros each year in reduced productivity
inNew research reveals that a largely ignored health problem, affecting nearly 40 million people in Europe…
-
Her Majesty the Queen of Sweden Addresses Salk Institute Meeting on Childhood Diseases in Stockholm
inHer Majesty the Queen of Sweden will officially open the Salk Institute’s annual International Council meeting at the Grand Hotel in Stockholm…
-
Ferring featured in the American Medical Review ™ television series
inFerring will be featured on the television programme American Medical Review this spring Season on American Public Television…
-
New website about primary nocturnal enuresis opened in Scandinavia
inFerring Pharmaceuticals is proud to announce the launch of the website www.dryallnight.com…
-
First international consultation on nocturia sheds light on neglected disease area
inAn international congress has been established by a panel of world leading experts to educate urologists and GPs about the neglected disease area called Nocturia. Nocturia means waking to urinate more than once a night regularly…
-
Ferring International Center opens for business
TIMELINES oninOn January 1st the new Ferring International Center building in Ørestad, Copenhagen opened for business. With its 20 floors, designed…
-
5-ASAs/mesalazine May Lower Colorectal Cancer Risk in Inflammatory Bowel Disease (IBD)
inMore evidence that taking your medication does a body good: Results of a recent study from the UK suggests that Inflammatory Bowel Disease patients (IBD) who take their 5-ASA/mesalazine medicine…
Author archive for pulse
Articles by: pulse